Physician profile
David T Styn
NPI 1750447447
$1,932.36
in general payments reported to CMS, 2019-2025
17 companies · $377 in 2025
The $377 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $242 · 2020: $117 · 2021: $154 · 2022: $229 · 2023: $396 · 2024: $418 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,191.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,190.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $443.25 | 2022-2025 | Durysta |
| Alcon Vision LLC | $337.90 | 2019-2025 | Rocklatan, Eysuvis, Precision7 |
| Sun Pharmaceutical Industries INC. | $334.48 | 2019-2023 | Cequa |
| Bausch & Lomb Americas INC. | $220.10 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Novartis Pharmaceuticals Corporation | $170.79 | 2019-2023 | |
| Oyster Point Pharma, INC. | $120.91 | 2022-2024 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $89.50 | 2019-2021 | |
| Dompe US, INC. | $27.13 | 2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $25.36 | 2024 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $24.24 | 2019 | |
| Sight Sciences, INC. | $22.58 | 2025 | Omni Surgical System |
| Shire North American Group INC | $21.38 | 2019 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $20.20 | 2019 | |
| Glaukos Corporation | $19.59 | 2025 | Idosetr |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Omeros Corporation | $18.97 | 2019 | |
| Biotissue Holdings INC. | $16.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Styn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.